PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Silo Pharma, Inc.
Filed: February 2, 2022
Period of Report: February 2, 2022
Accession Number: 0001213900-22-005082

View Document ↗ View on SEC.gov ↗